(Q43226736)

16 November 2017

Fecal calprotectin and clinical disease activity in pediatric ulcerative colitis (English)

1 reference

16 November 2017

1 reference

Kaija-Leena Kolho

1

1 reference

PMC publication ID

3600299

16 November 2017

Dan Turner

series ordinal

2

1 reference

16 November 2017

26 February 2013

1 reference

16 November 2017

ISRN Gastroenterology

1 reference

16 November 2017

2013

1 reference

16 November 2017

179024

1 reference

Creative Commons Attribution 3.0 Unported

16 November 2017

start time

26 February 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600299

Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600299

Classification of inflammatory bowel disease

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600299

Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600299

Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600299

Faecal calprotectin in children with clinically quiescent inflammatory bowel disease

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600299

Fecal calprotectin predicts the clinical course of acute severe ulcerative colitis.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600299

Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600299

Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600299

Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600299

Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease

15 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2013%2F179024

Limitations of Fecal Calprotectin At Diagnosis in Untreated Pediatric Crohnʼs Disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2013%2F179024

Effect of bowel cleansing for colonoscopy on fecal calprotectin levels in pediatric patients

21 January 2018

1 reference

12 December 2020

Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease

1 reference

12 December 2020

Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases

1 reference

12 December 2020

Fecal calprotectin is a useful marker for disease activity in pediatric patients with inflammatory bowel disease

1 reference

12 December 2020

A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis

1 reference

12 December 2020

Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis

1 reference

12 December 2020

Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease

1 reference

12 December 2020

Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease

1 reference

12 December 2020

Appraisal of the pediatric ulcerative colitis activity index (PUCAI)

1 reference

12 December 2020

Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease

1 reference

12 December 2020

The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease

1 reference

12 December 2020

Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response

1 reference

12 December 2020

Identifiers

DOI

10.1155/2013/179024

1 reference

16 November 2017

1 reference

PMC publication ID

3600299

16 November 2017

PubMed publication ID

23533791

1 reference

PMC publication ID

3600299